Bríd M. Ryan is an Irish biomedical scientist and cancer researcher. She was an investigator at the National Cancer Institute from 2013 to 2021. Early life and education

2020年6月2日 · New findings hint at therapies for African Americans with lung cancer. Bríd Ryan, Ph.D., M.P.H., is an NIH Stadtman Investigator in the Laboratory of Human Carcinogenesis at the Center for Cancer Research. Her research focuses on health disparities related to lung cancer across different populations.

BM Ryan, AI Robles, AC McClary, M Haznadar, ED Bowman, SR Pine, ... Cancer research 75 (3), 566-575, 2015. 68: 2015: Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.

Bríd RYAN, Principal Investigator | Cited by 4,228 | of National Institutes of Health, MD (NIH) | Read 79 publications | Contact Bríd RYAN

Bríd joined MiNA in 2021 and was promoted to Chief Scientific Officer in 2025. Previously, she spent 14 years at the National Cancer Institute in the USA where she led a team focussed on lung cancer research.

Bríd joined MiNA in 2021 and was promoted to Chief Scientific Officer in 2025. Previously, she spent 14 years at the National Cancer Institute in the USA where she led a team focussed on lung cancer research.

Brid Ryan microRNAs (miRNA) are small non-coding RNAs that target mRNA transcripts. Primarily, they bind to the 3′UTR of mRNA sequences and repress protein translation.

ePharmacy Programme, Health Service Executive, Dublin, Ireland. Publication Topics.

2018年10月26日 · The NCI Center for Cancer Research (CCR) is hosting a two-day national symposium and the program, chaired by Dr. Brid Ryan (NCI), will present recent advances in our understanding of the causes of cancer health disparities in the U.S. and globally.